The latest cancer news from the U.S. government's principal agency for cancer research.
  1. AI dual-stain approach improved accuracy, efficiency of cervical cancer screening in NCI study

    In a new study, an automated dual-stain method using artificial intelligence improved the accuracy and efficiency of cervical cancer screening compared with the current standard for follow-up of women who test positive with primary HPV screening.
  2. NIH scientists develop blood test to help improve liver cancer screening

    The new test is relatively simple and could improve screening for people who are at risk for developing hepatocellular carcinoma (HCC), the most common form of liver cancer. It could help doctors find and treat HCC early.
  3. Study identifies potential approach to treat severe respiratory distress in patients with COVID-19

    As described in an NCI Media Availability, early data from a clinical study suggest that treatment with the cancer drug acalabrutinib provided clinical benefit to a small group of patients with severe COVID-19.
  4. Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma

    In an NCI study, an alternative treatment regimen called dose-adjusted EPOCH-R that is less toxic than standard dose-intensive chemotherapy was highly effective for adults with Burkitt lymphoma across all age groups and independent of HIV status.
  5. Higher daily step count linked with lower all-cause mortality

    In a new study, higher daily step counts were associated with lower mortality risk from all causes. Researchers found that the number of steps taken each day, but not the intensity of the stepping, had a strong association with mortality.
  6. NCI study provides genetic insights into osteosarcoma in children

    A new study offers insight into genetic alterations associated with osteosarcoma, the most common bone tumor of children and adolescents, and the findings have implications for genetic testing of children with osteosarcoma and their families.
  7. NCI statement on clinical trials during COVID-19 pandemic

    Statement from the National Cancer Institute providing information regarding treatment of cancer patients and participation in clinical trials during the COVID-19 pandemic.
  8. In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1

    An NCI clinical trial finds the drug selumetinib improves outcomes for children with neurofibromatosis type 1 (NF1), shrinking inoperable tumors called plexiform neurofibromas, reducing pain, and improving function and overall quality of life.
  9. Annual Report to the Nation: Cancer death rates continue to decline

    The 2020 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline in the United States for all cancer sites combined. A companion study looked at Healthy People 2020 targets for four common cancers.
  10. Testing with combined biopsy method improves prostate cancer diagnosis in NCI study

    Testing for prostate cancer with a combined biopsy method led to more accurate diagnosis and prediction of the course of the disease in an NCI study. The method is poised to reduce the risk of prostate cancer overtreatment and undertreatment.